Syngulon is a synthetic biology startup that specializes in developing genetic technologies using bacteriocins to improve microbial fermentation. Our team of scientists works directly in the labs of our academic partners across Belgium, Brazil, France, Germany, The Netherlands, and the UK. We are dedicated to making microbial strains involved in industrial processes safer and more efficient through our innovative genetic technologies.

Bacteriocins are ribosomally-produced antimicrobial peptides that can be genetically modified to enhance their action. Syngulon is building a collection of natural and synthetic bacteriocins, harnessing the power of synthetic biology. We offer a unique selection technology that allows for controlled growth of microorganisms through the use of bacteriocin/immunity in any bacteria, yeast, or algae.

This technology has proven its efficacy at lab scale and can be customized for specific applications, such as production in sterile conditions or in open fermentors. Join us in revolutionizing microbial fermentation and contact Syngulon for more information